Skin Cancer Research Today is a free monthly online journal that collates and summarizes the latest research about Skin Cancer, including details on identification, causes, prevention, treatment.

Volume 4 (2007), Issue 9 (September)

1. Mexoryl: a review of an ultraviolet a filter.
   Plast Reconstr Surg, 120(4): 1071-5. [Abstract] [Full-text]
2. Incomplete excision of squamous cell carcinoma of the skin: a prospective observational study.
   Plast Reconstr Surg, 120(4): 910-6. [Abstract] [Full-text]
3. Review of extracorporeal photopheresis in early-stage (IA, IB, and IIA) cutaneous T-cell lymphoma.
   Photodermatol Photoimmunol Photomed, 23(5): 163-71. [Abstract] [Full-text]
4. Clinical characteristics of women presenting with skin-only recurrence of breast cancer.
   Am J Surg, 194(4): 494-6. [Abstract] [Full-text]
5. Multiple cutaneous ganglioneuromas in a dog.
   Vet Dermatol, 18(5): 360-4. [Abstract] [Full-text]
6. In vivo long-term effects of retinoic acid exposure in utero on induced hyperplastic epidermal foci in murine skin.
   Vet Dermatol, 18(5): 287-93. [Abstract] [Full-text]
7. Genital and nongenital nonmelanoma skin cancer: more epidemiological studies are needed.
   J Invest Dermatol, 127(10): 2296-9. [Abstract] [Full-text]
8. Recessive dystrophic epidermolysis bullosa-associated squamous-cell carcinoma: an enigmatic entity with complex pathogenesis.
   J Invest Dermatol, 127(10): 2295-6. [Abstract] [Full-text]
9. Multiple self-healing squamous epithelioma in different ethnic groups: more than a founder mutation disorder?
   J Invest Dermatol, 127(10): 2336-44. [Abstract] [Full-text]
10. Trends in nonmelanoma skin cancer mortality rates in the United States, 1969 through 2000.
    J Invest Dermatol, 127(10): 2323-7. [Abstract] [Full-text]
11. Comparison of a treatment strategy combining CCI-779 plus DTIC versus DTIC monotreatment in human melanoma in SCID mice.
    J Invest Dermatol, 127(10): 2411-7. [Abstract] [Full-text]
12. Human basal cell carcinoma is associated with Foxp3+ T cells in a Th2 dominant microenvironment.
    J Invest Dermatol, 127(10): 2391-8. [Abstract] [Full-text]
13. Blockade of death receptor-mediated pathways early in the signaling cascade coincides with distinct apoptosis resistance in cutaneous T-cell lymphoma cells.
    J Invest Dermatol, 127(10): 2425-37. [Abstract] [Full-text]
14. Galectin-1 knockdown increases sensitivity to temozolomide in a B16F10 mouse metastatic melanoma model.
    J Invest Dermatol, 127(10): 2399-410. [Abstract] [Full-text]
15. Patients with recessive dystrophic epidermolysis bullosa develop squamous-cell carcinoma regardless of type VII collagen expression.
    J Invest Dermatol, 127(10): 2438-44. [Abstract] [Full-text]
16. Expression of p53 in the evolution of squamous cell carcinoma: correlation with the histology of the lesion.
    J Am Acad Dermatol, 57(4): 669-76. [Abstract] [Full-text]
17. Staged excision versus Mohs micrographic surgery for lentigo maligna and lentigo maligna melanoma.
    J Am Acad Dermatol, 57(4): 659-64. [Abstract] [Full-text]
18. Screening, early detection, and trends for melanoma: current status (2000-2006) and future directions.
    J Am Acad Dermatol, 57(4): 555-72; quiz 573-6. [Abstract] [Full-text]
19. A phase III, randomized, open label study to evaluate the safety and efficacy of imiquimod 5% cream applied thrice weekly for 8 and 12 weeks in the treatment of low-risk nodular basal cell carcinoma.
    J Am Acad Dermatol, 57(4): 616-21. [Abstract] [Full-text]
20. Characterization of benign and malignant melanocytic skin lesions using optical coherence tomography in vivo.
    J Am Acad Dermatol, 57(4): 629-37. [Abstract] [Full-text]
21. Cutaneous infiltration by cancer.
    J Am Acad Dermatol, 57(4): 577-80. [Abstract] [Full-text]
22. Persistence of Mastomys natalensis papillomavirus in multiple organs identifies novel targets for infection.
    J Gen Virol, 88: 2670-8. [Abstract] [Full-text]
23. An update on plexiform fibrohistiocytic tumor and addition of 66 new cases from the Armed Forces Institute of Pathology, in honor of Franz M. Enzinger, MD.
    Ann Diagn Pathol, 11(5): 313-9. [Abstract] [Full-text]
24. Phase II trial of proteasome inhibitor bortezomib in patients with relapsed or refractory cutaneous T-cell lymphoma.
    J Clin Oncol, 25(27): 4293-7. [Abstract] [Full-text]
25. The evolution of the management of regional lymph nodes in melanoma.
    J Surg Oncol, 96(4): 316-21. [Abstract] [Full-text]
26. Squamous cell apocrine hidradenoma.
    J Cutan Pathol, 34(10): 801-3. [Abstract] [Full-text]
27. Monoclonal antibody Ber-EP4 reliably discriminates between microcystic adnexal carcinoma and basal cell carcinoma.
    J Cutan Pathol, 34(10): 782-7. [Abstract] [Full-text]
28. Epidemiology and treatment of extramammary Paget disease in the Netherlands.
    Eur J Surg Oncol, 33(8): 951-5. [Abstract] [Full-text]
29. Pigmented squamous cell carcinoma.
    Am J Dermatopathol, 29(5): 486-9. [Abstract] [Full-text]
30. Keloidal basal cell carcinoma.
    Am J Dermatopathol, 29(5): 485. [Abstract] [Full-text]
31. Basal cell carcinoma with matrical differentiation: expression of .-catenin and osteopontin.
    Am J Dermatopathol, 29(5): 470-4. [Abstract] [Full-text]
32. Metastasizing adenocarcinoma and multiple neoplastic proliferations arising in a nevus sebaceus.
    Am J Dermatopathol, 29(5): 462-6. [Abstract] [Full-text]
33. Usefulness of monoclonal antibody HIK1083 specific for gastric O-glycan in differentiating cutaneous metastasis of gastric cancer from primary sweat gland carcinoma.
    Am J Dermatopathol, 29(5): 452-6. [Abstract] [Full-text]
34. Myxoid dermatofibrosarcoma protuberans: clinicopathologic, immunohistochemical, and molecular analysis of eight cases.
    Am J Dermatopathol, 29(5): 443-8. [Abstract] [Full-text]
35. Diagnostically challenging spindle cell lipomas: a report of 34 "low-fat" and "fat-free" variants.
    Am J Dermatopathol, 29(5): 437-42. [Abstract] [Full-text]
36. Arginine metabolism in tumor-associated macrophages in cutaneous malignant melanoma: evidence from human and experimental tumors.
    Hum Pathol, 38(10): 1516-25. [Abstract] [Full-text]
37. Loss of heterozygosity analysis identifies genetic abnormalities in mycosis fungoides and specific loci associated with disease progression.
    Am J Surg Pathol, 31(10): 1552-6. [Abstract] [Full-text]
38. Immediate, optimal reconstruction of facial lentigo maligna and melanoma following total peripheral margin control.
    Plast Reconstr Surg, 120(5): 1249-55. [Abstract] [Full-text]
39. Incomplete excision of basal cell carcinoma: a prospective trial.
    Plast Reconstr Surg, 120(5): 1240-8. [Abstract] [Full-text]

© 2004-2008 Skin Cancer Research Today. All Rights Reserved.